Identification of antiviral antihistamines for COVID-19 repurposing
Leah R Reznikov, Michael H Norris, Rohit Vashisht, Andrew P Bluhm, Danmeng Li, Yan-Shin J. Liao, Ashley Brown, Atul J Butte, David A Ostrov
Biochemical and Biophysical Research Communications, doi:10.1016/j.bbrc.2020.11.095
a b s t r a c t There is an urgent need to identify therapies that prevent SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Although repurposed drugs with favorable safety profiles could have significant benefit, widely available prevention or treatment options for COVID-19 have yet to be identified. Efforts to identify approved drugs with in vitro activity against SARS-CoV-2 resulted in identification of antiviral sigma-1 receptor ligands, including antihistamines in the histamine-1 receptor binding class. We identified antihistamine candidates for repurposing by mining electronic health records of usage in population of more than 219,000 subjects tested for SARS-CoV-2. Usage of diphenhydramine, hydroxyzine and azelastine was associated with reduced incidence of SARS-CoV-2 positivity in subjects greater than age 61. We found diphenhydramine, hydroxyzine and azelastine to exhibit direct antiviral activity against SARS-CoV-2 in vitro. Although mechanisms by which specific antihistamines exert antiviral effects is not clear, hydroxyzine, and possibly azelastine, bind Angiotensin Converting Enzyme-2 (ACE2) and the sigma-1 receptor as off-targets. Clinical studies are needed to measure the effectiveness of diphenhydramine, hydroxyzine and azelastine for disease prevention, for early intervention, or as adjuvant therapy for severe COVID-19.
Appendix A. Supplementary data Supplementary data related to this article can be found at https://doi.org/10.1016/j.bbrc.2020.11.095.
References
Basile, Paul, Mirchevich, Kuijpers, Costa, Modulation of (þ)-[3H]pentazocine binding to Guinea pig cerebellum by divalent cations, Mol. Pharmacol
Blyden, Greenblatt, Scavone, Shader, Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration, J. Clin. Pharmacol,
doi:10.1002/j.1552-4604.1986.tb02946.xCore, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing
Cottam, Whelband, Wileman, Coronavirus NSP6 restricts autophagosome expansion, Autophagy,
doi:10.4161/auto.29309Derendorf, Munzel, Petzold, Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray, Br. J. Clin. Pharmacol,
doi:10.1111/j.1365-2125.2012.04222.xDyall, Gross, Kindrachuk, Middle east respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies, Drugs,
doi:10.1007/s40265-017-0830-1Fouda, Hobbs, Stambaugh, Sensitive assay for determination of hydroxyzine in plasma and its human pharmacokinetics, J. Pharmaceut. Sci
Freedberg, Conigliaro, Wang, Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: a propensity score matched retrospective cohort study, Gastroenterology
Gautret, Lagier, Parola, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int. J. Antimicrob. Agents
Gordon, Jang, Bouhaddou, A SARS-CoV-2-Human Protein-Protein Interaction Map reveals Drug Targets and Potential Drug-repurposing, bioRxiv
Hernandez Prada, Ferreira, Katovich, Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents, Hypertension,
doi:10.1161/HYPERTENSIONAHA.107.108944Huentelman, Zubcevic, Hernandez Prada, Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor, Hypertension
Huentelman, Zubcevic, Hernandez Prada, Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor, Hypertension
Joshi, Joshi, Degani, Tackling SARS-CoV-2: proposed targets and repurposed drugs, Future Med. Chem,
doi:10.4155/fmc-2020-0147Liao, Kuan, Guevara, Acid exposure disrupts mucus secretion and impairs mucociliary transport in neonatal piglet airways, Am. J. Physiol. Lung Cell Mol. Physiol,
doi:10.1152/ajplung.00025.2020Lieberman-Cribbin, Rapp, Alpert, Tuminello, Taioli, The impact of asthma on mortality in patients with COVID-19, Chest
Liu, Cao, Xu, Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov,
doi:10.1038/s41421-020-0156-0Morris, Huey, Lindstrom, AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility, J. Comput. Chem,
doi:10.1002/jcc.21256Mossel, Huang, Narayanan, Makino, Tesh et al., Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication, J. Virol
Poduri, Joshi, Jagadeesh, Drugs targeting various stages of the SARS-CoV-2 life cycle: exploring promising drugs for the treatment of covid-19, Cell. Signal
Rogosnitzky, Berkowitz, Jadad, Delivering benefits at speed through real-world repurposing of off-patent drugs: the COVID-19 pandemic as a case in point, JMIR Public Health Surveill,
doi:10.2196/19199Schmidt, Zheng, Gurpinar, Koehl, Manglik et al., Crystal structure of the human sigma1 receptor, Nature,
doi:10.1038/nature17391Towler, Staker, Prasad, ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis, J. Biol. Chem,
doi:10.1074/jbc.M311191200Vincent, Bergeron, Benjannet, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Virol. J
Wang, Cao, Zhang, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res,
doi:10.1038/s41422-020-0282-0Yan, Zhang, Li, Xia, Guo et al., Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science,
doi:10.1126/science.abb2762{ 'indexed': { 'date-parts': [[2023, 12, 26]],
'date-time': '2023-12-26T21:17:45Z',
'timestamp': 1703625465935},
'reference-count': 32,
'publisher': 'Elsevier BV',
'license': [ { 'start': { 'date-parts': [[2021, 1, 1]],
'date-time': '2021-01-01T00:00:00Z',
'timestamp': 1609459200000},
'content-version': 'tdm',
'delay-in-days': 0,
'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}],
'funder': [ { 'DOI': '10.13039/100000002',
'name': 'National Institutes of Health',
'doi-asserted-by': 'publisher'},
{ 'DOI': '10.13039/100000002',
'name': 'National Institutes of Health',
'doi-asserted-by': 'publisher'}],
'content-domain': {'domain': ['elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2021, 1]]},
'DOI': '10.1016/j.bbrc.2020.11.095',
'type': 'journal-article',
'created': {'date-parts': [[2020, 12, 3]], 'date-time': '2020-12-03T14:44:42Z', 'timestamp': 1607006682000},
'page': '173-179',
'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy',
'source': 'Crossref',
'is-referenced-by-count': 69,
'title': 'Identification of antiviral antihistamines for COVID-19 repurposing',
'prefix': '10.1016',
'volume': '538',
'author': [ { 'ORCID': 'http://orcid.org/0000-0002-4074-9070',
'authenticated-orcid': False,
'given': 'Leah R.',
'family': 'Reznikov',
'sequence': 'first',
'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-5285-0432',
'authenticated-orcid': False,
'given': 'Michael H.',
'family': 'Norris',
'sequence': 'additional',
'affiliation': []},
{'given': 'Rohit', 'family': 'Vashisht', 'sequence': 'additional', 'affiliation': []},
{'given': 'Andrew P.', 'family': 'Bluhm', 'sequence': 'additional', 'affiliation': []},
{'given': 'Danmeng', 'family': 'Li', 'sequence': 'additional', 'affiliation': []},
{'given': 'Yan-Shin J.', 'family': 'Liao', 'sequence': 'additional', 'affiliation': []},
{'given': 'Ashley', 'family': 'Brown', 'sequence': 'additional', 'affiliation': []},
{'given': 'Atul J.', 'family': 'Butte', 'sequence': 'additional', 'affiliation': []},
{ 'ORCID': 'http://orcid.org/0000-0002-4696-875X',
'authenticated-orcid': False,
'given': 'David A.',
'family': 'Ostrov',
'sequence': 'additional',
'affiliation': []}],
'member': '78',
'reference': [ { 'issue': '2',
'key': '10.1016/j.bbrc.2020.11.095_bib1',
'doi-asserted-by': 'crossref',
'DOI': '10.2196/19199',
'article-title': 'Delivering benefits at speed through real-world repurposing of '
'off-patent drugs: the COVID-19 pandemic as a case in point',
'volume': '6',
'author': 'Rogosnitzky',
'year': '2020',
'journal-title': 'JMIR Public Health Surveill'},
{ 'issue': '1',
'key': '10.1016/j.bbrc.2020.11.095_bib2',
'doi-asserted-by': 'crossref',
'first-page': '105949',
'DOI': '10.1016/j.ijantimicag.2020.105949',
'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results '
'of an open-label non-randomized clinical trial',
'volume': '56',
'author': 'Gautret',
'year': '2020',
'journal-title': 'Int. J. Antimicrob. Agents'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib3',
'doi-asserted-by': 'crossref',
'DOI': '10.1038/s41421-020-0156-0',
'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is '
'effective in inhibiting SARS-CoV-2 infection in\xa0vitro',
'volume': '6',
'author': 'Liu',
'year': '2020',
'journal-title': 'Cell Discov'},
{ 'issue': '3',
'key': '10.1016/j.bbrc.2020.11.095_bib4',
'doi-asserted-by': 'crossref',
'first-page': '269',
'DOI': '10.1038/s41422-020-0282-0',
'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged '
'novel coronavirus (2019-nCoV) in\xa0vitro',
'volume': '30',
'author': 'Wang',
'year': '2020',
'journal-title': 'Cell Res.'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib5',
'doi-asserted-by': 'crossref',
'DOI': '10.1186/1743-422X-2-69',
'article-title': 'Chloroquine is a potent inhibitor of SARS coronavirus infection and '
'spread',
'volume': '2',
'author': 'Vincent',
'year': '2005',
'journal-title': 'Virol. J.'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib6',
'series-title': 'A\xa0SARS-CoV-2-Human Protein-Protein Interaction Map reveals Drug '
'Targets and Potential Drug-repurposing',
'author': 'Gordon',
'year': '2020'},
{ 'issue': '18',
'key': '10.1016/j.bbrc.2020.11.095_bib7',
'doi-asserted-by': 'crossref',
'first-page': '1935',
'DOI': '10.1007/s40265-017-0830-1',
'article-title': 'Middle east respiratory syndrome and severe acute respiratory syndrome: '
'current therapeutic options and potential targets for novel therapies',
'volume': '77',
'author': 'Dyall',
'year': '2017',
'journal-title': 'Drugs'},
{ 'issue': '1',
'key': '10.1016/j.bbrc.2020.11.095_bib8',
'doi-asserted-by': 'crossref',
'DOI': '10.3390/microorganisms8010085',
'article-title': 'The use of antimalarial drugs against viral infection',
'volume': '8',
'author': 'D’Alessandro',
'year': '2020',
'journal-title': 'Microorganisms'},
{ 'issue': '6485',
'key': '10.1016/j.bbrc.2020.11.095_bib9',
'doi-asserted-by': 'crossref',
'first-page': '1444',
'DOI': '10.1126/science.abb2762',
'article-title': 'Structural basis for the recognition of SARS-CoV-2 by full-length human '
'ACE2',
'volume': '367',
'author': 'Yan',
'year': '2020',
'journal-title': 'Science'},
{ 'issue': '17',
'key': '10.1016/j.bbrc.2020.11.095_bib10',
'doi-asserted-by': 'crossref',
'first-page': '17996',
'DOI': '10.1074/jbc.M311191200',
'article-title': 'ACE2 X-ray structures reveal a large hinge-bending motion important for '
'inhibitor binding and catalysis',
'volume': '279',
'author': 'Towler',
'year': '2004',
'journal-title': 'J.\xa0Biol. Chem.'},
{ 'issue': '6',
'key': '10.1016/j.bbrc.2020.11.095_bib11',
'doi-asserted-by': 'crossref',
'first-page': '903',
'DOI': '10.1161/01.HYP.0000146120.29648.36',
'article-title': 'Structure-based discovery of a novel angiotensin-converting enzyme 2 '
'inhibitor',
'volume': '44',
'author': 'Huentelman',
'year': '2004',
'journal-title': 'Hypertension'},
{ 'issue': '5',
'key': '10.1016/j.bbrc.2020.11.095_bib12',
'doi-asserted-by': 'crossref',
'first-page': '1312',
'DOI': '10.1161/HYPERTENSIONAHA.107.108944',
'article-title': 'Structure-based identification of small-molecule angiotensin-converting '
'enzyme 2 activators as novel antihypertensive agents',
'volume': '51',
'author': 'Hernandez Prada',
'year': '2008',
'journal-title': 'Hypertension'},
{ 'issue': '8',
'key': '10.1016/j.bbrc.2020.11.095_bib13',
'doi-asserted-by': 'crossref',
'first-page': '878',
'DOI': '10.1177/1087057111413919',
'article-title': 'Prediction of off-target effects on angiotensin-converting enzyme 2',
'volume': '16',
'author': 'Kulemina',
'year': '2011',
'journal-title': 'J.\xa0Biomol. Screen'},
{ 'issue': '17',
'key': '10.1016/j.bbrc.2020.11.095_bib14',
'doi-asserted-by': 'crossref',
'first-page': '1579',
'DOI': '10.4155/fmc-2020-0147',
'article-title': 'Tackling SARS-CoV-2: proposed targets and repurposed drugs',
'volume': '12',
'author': 'Joshi',
'year': '2020',
'journal-title': 'Future Med. Chem.'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib15',
'doi-asserted-by': 'crossref',
'first-page': '109721',
'DOI': '10.1016/j.cellsig.2020.109721',
'article-title': 'Drugs targeting various stages of the SARS-CoV-2 life cycle: exploring '
'promising drugs for the treatment of covid-19',
'volume': '74',
'author': 'Poduri',
'year': '2020',
'journal-title': 'Cell. Signal.'},
{ 'issue': '7816',
'key': '10.1016/j.bbrc.2020.11.095_bib16',
'doi-asserted-by': 'crossref',
'first-page': '459',
'DOI': '10.1038/s41586-020-2286-9',
'article-title': 'A\xa0SARS-CoV-2 protein interaction map reveals targets for drug '
'repurposing',
'volume': '583',
'author': 'Gordon',
'year': '2020',
'journal-title': 'Nature'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib17',
'doi-asserted-by': 'crossref',
'article-title': 'Discovery of SARS-CoV-2 antiviral drugs through large-scale compound '
'repurposing',
'author': 'Riva',
'year': '2020',
'journal-title': 'Nature',
'DOI': '10.1038/s41586-020-2577-1'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib18',
'doi-asserted-by': 'crossref',
'article-title': 'Famotidine use is associated with improved clinical outcomes in '
'hospitalized COVID-19 patients: a propensity score matched '
'retrospective cohort study',
'author': 'Freedberg',
'year': '2020',
'journal-title': 'Gastroenterology',
'DOI': '10.1053/j.gastro.2020.05.053'},
{ 'issue': '16',
'key': '10.1016/j.bbrc.2020.11.095_bib19',
'doi-asserted-by': 'crossref',
'first-page': '2785',
'DOI': '10.1002/jcc.21256',
'article-title': 'AutoDock4 and AutoDockTools4: automated docking with selective receptor '
'flexibility',
'volume': '30',
'author': 'Morris',
'year': '2009',
'journal-title': 'J.\xa0Comput. Chem.'},
{ 'issue': '7600',
'key': '10.1016/j.bbrc.2020.11.095_bib20',
'doi-asserted-by': 'crossref',
'first-page': '527',
'DOI': '10.1038/nature17391',
'article-title': 'Crystal structure of the human sigma1 receptor',
'volume': '532',
'author': 'Schmidt',
'year': '2016',
'journal-title': 'Nature'},
{ 'issue': '1',
'key': '10.1016/j.bbrc.2020.11.095_bib21',
'doi-asserted-by': 'crossref',
'first-page': '1',
'DOI': '10.1080/15548627.2015.1100356',
'article-title': 'Guidelines for the use and interpretation of assays for monitoring '
'autophagy (3rd edition)',
'volume': '12',
'author': 'Klionsky',
'year': '2016',
'journal-title': 'Autophagy'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib22',
'series-title': 'R: A Language and Environment for Statistical Computing',
'year': '2014'},
{ 'issue': '6',
'key': '10.1016/j.bbrc.2020.11.095_bib23',
'doi-asserted-by': 'crossref',
'first-page': '3846',
'DOI': '10.1128/JVI.79.6.3846-3850.2005',
'article-title': 'Exogenous ACE2 expression allows refractory cell lines to support '
'severe acute respiratory syndrome coronavirus replication',
'volume': '79',
'author': 'Mossel',
'year': '2005',
'journal-title': 'J.\xa0Virol.'},
{ 'issue': '5',
'key': '10.1016/j.bbrc.2020.11.095_bib24',
'doi-asserted-by': 'crossref',
'first-page': 'L873',
'DOI': '10.1152/ajplung.00025.2020',
'article-title': 'Acid exposure disrupts mucus secretion and impairs mucociliary '
'transport in neonatal piglet airways',
'volume': '318',
'author': 'Liao',
'year': '2020',
'journal-title': 'Am. J. Physiol. Lung Cell Mol. Physiol.'},
{ 'issue': '5',
'key': '10.1016/j.bbrc.2020.11.095_bib25',
'first-page': '882',
'article-title': 'Modulation of (+)-[3H]pentazocine binding to Guinea pig cerebellum by '
'divalent cations',
'volume': '42',
'author': 'Basile',
'year': '1992',
'journal-title': 'Mol. Pharmacol.'},
{ 'issue': '8',
'key': '10.1016/j.bbrc.2020.11.095_bib26',
'doi-asserted-by': 'crossref',
'first-page': '1426',
'DOI': '10.4161/auto.29309',
'article-title': 'Coronavirus NSP6 restricts autophagosome expansion',
'volume': '10',
'author': 'Cottam',
'year': '2014',
'journal-title': 'Autophagy'},
{ 'issue': '6',
'key': '10.1016/j.bbrc.2020.11.095_bib27',
'doi-asserted-by': 'crossref',
'first-page': '903',
'DOI': '10.1161/01.HYP.0000146120.29648.36',
'article-title': 'Structure-based discovery of a novel angiotensin-converting enzyme 2 '
'inhibitor',
'volume': '44',
'author': 'Huentelman',
'year': '2004',
'journal-title': 'Hypertension'},
{ 'issue': '11',
'key': '10.1016/j.bbrc.2020.11.095_bib28',
'doi-asserted-by': 'crossref',
'first-page': '1456',
'DOI': '10.1002/jps.2600681134',
'article-title': 'Sensitive assay for determination of hydroxyzine in plasma and its '
'human pharmacokinetics',
'volume': '68',
'author': 'Fouda',
'year': '1979',
'journal-title': 'J.\xa0Pharmaceut. Sci.'},
{ 'issue': '7',
'key': '10.1016/j.bbrc.2020.11.095_bib29',
'doi-asserted-by': 'crossref',
'first-page': '529',
'DOI': '10.1002/j.1552-4604.1986.tb02946.x',
'article-title': 'Pharmacokinetics of diphenhydramine and a demethylated metabolite '
'following intravenous and oral administration',
'volume': '26',
'author': 'Blyden',
'year': '1986',
'journal-title': 'J.\xa0Clin. Pharmacol.'},
{ 'issue': '1',
'key': '10.1016/j.bbrc.2020.11.095_bib30',
'doi-asserted-by': 'crossref',
'first-page': '125',
'DOI': '10.1111/j.1365-2125.2012.04222.x',
'article-title': 'Bioavailability and disposition of azelastine and fluticasone '
'propionate when delivered by MP29-02, a novel aqueous nasal spray',
'volume': '74',
'author': 'Derendorf',
'year': '2012',
'journal-title': 'Br. J. Clin. Pharmacol.'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib31',
'doi-asserted-by': 'crossref',
'article-title': 'Severe covid-19',
'author': 'Berlin',
'year': '2020',
'journal-title': 'N.\xa0Engl. J. Med.',
'DOI': '10.1056/NEJMcp2009575'},
{ 'key': '10.1016/j.bbrc.2020.11.095_bib32',
'doi-asserted-by': 'crossref',
'article-title': 'The impact of asthma on mortality in patients with COVID-19',
'author': 'Lieberman-Cribbin',
'year': '2020',
'journal-title': 'Chest',
'DOI': '10.1016/j.chest.2020.05.575'}],
'container-title': 'Biochemical and Biophysical Research Communications',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0006291X20321409?httpAccept=text/xml',
'content-type': 'text/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://api.elsevier.com/content/article/PII:S0006291X20321409?httpAccept=text/plain',
'content-type': 'text/plain',
'content-version': 'vor',
'intended-application': 'text-mining'}],
'deposited': { 'date-parts': [[2021, 3, 23]],
'date-time': '2021-03-23T15:44:28Z',
'timestamp': 1616514268000},
'score': 1,
'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0006291X20321409'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 1]]},
'references-count': 32,
'alternative-id': ['S0006291X20321409'],
'URL': 'http://dx.doi.org/10.1016/j.bbrc.2020.11.095',
'relation': {},
'ISSN': ['0006-291X'],
'subject': ['Cell Biology', 'Molecular Biology', 'Biochemistry', 'Biophysics'],
'container-title-short': 'Biochemical and Biophysical Research Communications',
'published': {'date-parts': [[2021, 1]]},
'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'},
{ 'value': 'Identification of antiviral antihistamines for COVID-19 repurposing',
'name': 'articletitle',
'label': 'Article Title'},
{ 'value': 'Biochemical and Biophysical Research Communications',
'name': 'journaltitle',
'label': 'Journal Title'},
{ 'value': 'https://doi.org/10.1016/j.bbrc.2020.11.095',
'name': 'articlelink',
'label': 'CrossRef DOI link to publisher maintained version'},
{'value': 'article', 'name': 'content_type', 'label': 'Content Type'},
{ 'value': '© 2020 Elsevier Inc. All rights reserved.',
'name': 'copyright',
'label': 'Copyright'}]}
